Evaluation in Small Development Non-profits: Deadends, Victories, and Alternative Routes

被引：0
|
作者：
Allum, Cliff [1 ]
机构：
[1] Univ Birmingham, Sect Res Ctr 3, Dept Social Policy, Birmingham, England
来源：
COMMUNITY DEVELOPMENT JOURNAL | 2023年 / 58卷 / 01期
关键词：
D O I：
10.1093/cdj/bsab055
中图分类号：
F0 [经济学]; F1 [世界各国经济概况、经济史、经济地理]; C [社会科学总论];
学科分类号：
0201 ; 020105 ; 03 ; 0303 ;
摘要：
引用
收藏
页码：177 / 180
页数：4
相关论文
共 34 条
  • [21] Development and evaluation of CD44-targeted lipid-based nanoparticles in an orthotopic non-small cell lung cancer xenograft mouse model
    Benhabbour, Soumya
    DeSimone, Joseph
    Mumper, Russell
    Webster, Amy
    Luft, Christopher
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 249
  • [22] Development and in vitro evaluation of core-shell type lipid-polymer hybrid nanoparticles for the delivery of erlotinib in non-small cell lung cancer
    Mandal, Bivash
    Mittal, Nivesh K.
    Balabathula, Pavan
    Thoma, Laura A.
    Wood, George C.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 81 : 162 - 171
  • [23] Development of Brain Metastases in Patients With Non-Small Cell Lung Cancer and No Brain Metastases at Initial Staging Evaluation: Cumulative Incidence and Risk Factor Analysis
    Kim, Minjae
    Suh, Chong Hyun
    Lee, Sang Min
    Park, Ji Eun
    Kim, Ho Cheol
    Kim, Seon-Ok
    Aizer, Ayal A.
    Yanagihara, Ted K.
    Bai, Harrison X.
    Guenette, Jeffrey P.
    Huang, Raymond Y.
    Kim, Ho Sung
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2021, 217 (05) : 1184 - 1193
  • [24] Development and In Vitro Evaluation of Crizotinib-Loaded Lipid–Polymer Hybrid Nanoparticles Using Box–Behnken Design in Non-small Cell Lung Cancer
    Pelinsu Korucu Aktas
    Ipek Baysal
    Samiye Yabanoglu-Ciftci
    Betul Arica
    AAPS PharmSciTech, 24
  • [25] Development of paclitaxel loaded pegylated gelatin targeted nanoparticles for improved treatment efficacy in non-small cell lung cancer (NSCLC): an in vitro and in vivo evaluation study
    Gu, Minwei
    Luan, Jun
    Song, Kun
    Qiu, Cao
    Zhang, XiaoLi
    Zhang, Mingyong
    ACTA BIOCHIMICA POLONICA, 2021, 68 (04) : 583 - 591
  • [26] Development and In Vitro Evaluation of Crizotinib-Loaded Lipid-Polymer Hybrid Nanoparticles Using Box-Behnken Design in Non-small Cell Lung Cancer
    Aktas, Pelinsu Korucu
    Baysal, Ipek
    Yabanoglu-Ciftci, Samiye
    Arica, Betul
    AAPS PHARMSCITECH, 2023, 24 (07)
  • [27] Development and Evaluation of a Quantitative Systems Pharmacology Model for Mechanism Interpretation and Efficacy Prediction of Atezolizumab in Combination with Carboplatin and Nab-Paclitaxel in Patients with Non-Small-Cell Lung Cancer
    Wang, Chen-Yu
    Dai, Hao-Ran
    Tan, Yu-Ping
    Yang, Di-Hong
    Niu, Xiao-Min
    Han, Lu
    Wang, Wen
    Ma, Ling-Ling
    Julku, Aleksi
    Jiao, Zheng
    PHARMACEUTICALS, 2024, 17 (02)
  • [28] Evaluation of the association between predictive factors and the development of immune-related adverse events and prognostic factors for chemoimmunotherapy in patients with non-small cell lung cancer: A multicenter retrospective study
    Ozawa, Ryota
    Sonehara, Kei
    Hachiya, Tsutomu
    Nozawa, Shuhei
    Agatsuma, Toshihiko
    Yamamoto, Hiroshi
    Kato, Akane
    Matsuo, Akemi
    Hirabayashi, Taro
    Araki, Taisuke
    Komatsu, Masamichi
    Tateishi, Kazunari
    Hanaoka, Masayuki
    CANCER MEDICINE, 2024, 13 (15):
  • [29] Development and evaluation of a proxy for baseline ECOG PS in advanced non-small cell lung cancer (aNSCLC), bladder cancer (aBCa), and melanoma (aMM): An electronic health records (EHR) study.
    Sadetsky, Natalia
    Chuo, Ching-Yi
    Davidoff, Amy J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [30] DEVELOPMENT AND EVALUATION OF A LIQUID BEAD ARRAY ASSAY FOR THE EXPRESSION OF VEGF121, VEGF165 AND VEGF189SPLICE VARIANTS IN NON-SMALL CELL LUNG CANCER (NSCLC)
    Parisi, K.
    Markou, A.
    Tsaroucha, E.
    Kaklamanis, L.
    Lianidou, E. S.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S252 - S252
1234